Indian Naproxen Exporters: Complete Supplier Ranking with Market Share — 192 Manufacturers (2026) — TransData Nexus

Q: Who is the largest naproxen supplier from India?

MYLAN LABORATORIES LIMITED is the largest naproxen exporter from India with a 17.4% market share and export value of $23.3M.

Q: How many naproxen suppliers are there in India?

There are 192 active naproxen exporters in India, collectively shipping $133.8M worth of naproxen across 3,414 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top naproxen suppliers from India?

The top 5 naproxen suppliers from India — MYLAN LABORATORIES LIMITED, UNICHEM LABORATORIES LIMITED, GLENMARK PHARMACEUTICALS LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED, GRANULES INDIA LIMITED — together control 60.2% of total naproxen export value from India.

Suresh Sormare

Naproxen

India Pharmaceutical Trade Intelligence

$133.8M192 Suppliers76 CountriesHS 30049069

ExportsIndia → UNITED STATES42.1%India → CANADA21.1%

ImportsUNITED STATES → India$391.7K GERMANY → India$185.0K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

Naproxen Suppliers from India (2026) — 192 Exporters, $133.8M Market | TransData Nexus | TransData Nexus

Who Exports Naproxen from India — 192 Suppliers Behind a $133.8M Market

India's naproxen export market is supplied by 192 active exporters who collectively shipped $133.8M across 3,414 shipments. MYLAN LABORATORIES LIMITED leads with a 17.4% market share, followed by UNICHEM LABORATORIES LIMITED and GLENMARK PHARMACEUTICALS LIMITED. The top 5 suppliers together control 60.2% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Naproxen Suppliers & Exporters — 192 manufacturers, $133.8M export market, top destinations and formulations — Naproxen supplier data — 192 exporters · $133.8M market · 3,414 shipmentsTransData Nexus · Indian Customs Data

Top Naproxen Exporters from India — Ranked by Export Value

MYLAN LABORATORIES LIMITED is the leading naproxen exporter from India, holding a 17.4% share of the $133.8M market across 3,414 shipments from 192 exporters. The top 5 suppliers — MYLAN LABORATORIES LIMITED, UNICHEM LABORATORIES LIMITED, GLENMARK PHARMACEUTICALS LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED, GRANULES INDIA LIMITED — collectively control 60.2% of total export value, indicating a moderately concentrated market. Individual shares are: MYLAN LABORATORIES LIMITED (17.4%), UNICHEM LABORATORIES LIMITED (16.2%), GLENMARK PHARMACEUTICALS LIMITED (10.5%), AMNEAL PHARMACEUTICALS PRIVATE LIMITED (9.7%), GRANULES INDIA LIMITED (6.3%).

Top Naproxen Exporters from India

Ranked by export value · 192 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Naproxen Exporters from India — Ranked by Export Value. 192 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Naproxen exporters

Certification and compliance status for top Naproxen suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Glenmark Pharmaceuticals Limited	Warning Letter, July 2025	Unknown	Unknown	Not verified	FDA issued a warning letter citing significant CGMP violations at the Pithampur
Granules India Limited	Warning Letter, February	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP violations at the Gagillapur facility.
Aurobindo Pharma Limited	Warning Letter, June 2019	Unknown	Unknown	Not verified	FDA issued a warning letter in 2019; compliance achieved by February 2023.
Unichem Laboratories Limited	Approved	Unknown	Unknown	45 approved ANDAs	Holds 45 approved ANDAs and 75 US DMFs.
Mylan Laboratories Limited	Warning Letter, 2020	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP violations at Unit 8 facility.
Dr. Reddy's Laboratories Limited	Warning Letter, 2015	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP violations at Srikakulam facility.
Marksans Pharma Limited	Warning Letter, 2015	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP violations at Goa facility.
Apotex Research Private Limited	Warning Letter, 2014	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP violations at Bangalore facility.
Medreich Limited	Warning Letter, 2015	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP violations at Bangalore facility.
S Kant Healthcare Limited	Warning Letter, 2015	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP violations at Vapi facility.

TransData Nexus reviewed the regulatory standing of 10 leading Naproxen exporters from India. 1 hold US FDA facility approvals, 0 maintain WHO-GMP certification, and 0 are EU GMP compliant. 9 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Naproxen sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for the production of Active Pharmaceutical Ingredients (APIs). Companies like Dr. Reddy's Laboratories Ltd., headquartered in Hyderabad, have established themselves as major players in the Naproxen market. Dr. Reddy's operates a dedicated cGMP facility in Cuernavaca, Mexico, with a total capacity exceeding 1,500 metric tons for Naproxen API production. This facility ensures a robust supply chain and consistent quality, catering to global pharmaceutical needs.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Alembic Pharmaceuticals, based in Vadodara, exemplifies this specialization. The company manufactures and markets a range of pharmaceutical products, including formulations for therapeutic areas such as cardiology, dermatology, and infectious diseases. Their operations include manufacturing facilities in Gujarat and research and development centers in India and the United States.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad region serves as a critical export gateway for pharmaceutical products. Cipla, headquartered in Mumbai, has a significant presence in this area. The company operates 34 manufacturing units across India and has a presence in over 80 countries. Cipla's extensive manufacturing capabilities and strategic location facilitate efficient export operations, contributing to India's prominence in the global pharmaceutical market.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Naproxen exporters from India

October 2024

M&A

Glenmark Pharmaceuticals Limited — Glenmark divests 75% stake in Glenmark Life Sciences to Nirma

In October 2024, Glenmark Pharmaceuticals Limited completed the divestment of a 75% stake in its subsidiary, Glenmark Life Sciences, to Nirma Limited for approximately ₹5,651 crore. IMPACT: This divestment may lead to a strategic realignment of Glenmark's focus, potentially affecting its Naproxen production and export capabilities.

Impact: This divestment may lead to a strategic realignment of Glenmark's focus, potentially affecting its Naproxen production and export capabilities.

July 2025

Regulatory

Glenmark Pharmaceuticals Limited — FDA issues warning letter to Glenmark's Indore facility

On July 11, 2025, the FDA issued a warning letter to Glenmark Pharmaceuticals Limited's Indore facility, citing significant violations of Current Good Manufacturing Practice (CGMP) regulations, including inadequate investigation of batch failures. IMPACT: Regulatory scrutiny may disrupt Glenmark's production schedules, potentially impacting Naproxen exports.

Impact: Regulatory scrutiny may disrupt Glenmark's production schedules, potentially impacting Naproxen exports.

Common Questions — Naproxen Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which naproxen supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, MYLAN LABORATORIES LIMITED leads with 55 recorded shipments worth $23.3M. UNICHEM LABORATORIES LIMITED (276 shipments) and GLENMARK PHARMACEUTICALS LIMITED (303 shipments) are also established high-volume exporters.

Q How many naproxen manufacturers are there in India?

India has 192 active naproxen exporters with a combined export market of $133.8M across 3,414 shipments to 76 countries. The top 5 suppliers hold 60.2% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for naproxen from India?

Average FOB unit price: $15.88 per unit, ranging from $0.01 to $1678.68. Average shipment value: $39.2K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Naproxen

Naproxen

Who Exports Naproxen from India — 192 Suppliers Behind a $133.8M Market

Top Naproxen Exporters from India — Ranked by Export Value

Top Naproxen Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Glenmark Pharmaceuticals Limited — Glenmark divests 75% stake in Glenmark Life Sciences to Nirma

Glenmark Pharmaceuticals Limited — FDA issues warning letter to Glenmark's Indore facility

Common Questions — Naproxen Suppliers from India

Q Which naproxen supplier from India is the most reliable for bulk orders?

Q How many naproxen manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for naproxen from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Glenmark Pharmaceuticals Limited, Granules India Limited, Unichem Laboratories Limited — Indian drugmakers recall products in US market

Analysis Methodology